Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Aza A. Agieva"'
2
Effect of secondary metabolites of Berberis vulgaris and Petasites hybridus on apoptosis and cell cycle of HeLa cell line
Autor: Irina L. Popova, Faina V. Alieva, Aza A. Agieva, Oleg N. Burov, Yaroslav S. Enin, Natalia M. Tikhanovskaya, Marina M. Sergeeva, Valeriya S Myagkova, Liubov Yu Vladimirova, Ludmila A. Ryadinskaya, Natalia A. Abramova, Maria A. Teplyakova, Elena Yu. Zlatnik, Kristina A. Novoselova
Publikováno v: Journal of Clinical Oncology. 39:e15063-e15063
e15063 Background: The study of the possible antitumor activity of secondary plant metabolites either in the form of individual agents or in combination with clinically used drugs is considered as a promising direction in the therapy of malignant tum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::730594e5f95625fc1110df34b6ac6d52
https://doi.org/10.1200/jco.2021.39.15_suppl.e15063
Zobrazit plný text záznamu
5
The use of anti-EGFR monoclonal antibodies-EGFR blockers in the comprehensive treatment of metastatic colorectal cancer with or without the surgical removal of metastases
Autor: Aza A. Agieva, T A Snezhko, L Yu Vladimirova, Oleg I. Kit, Natalia Yu. Samaneva, Irina L. Popova, Sergey N. Kabanov, A. E. Storozhakova, Elena A. Kalabanova, N. M Tkhanovskaya, Kristina A. Novoselova, Nataliya Abramova
Publikováno v: Russian Journal of Oncology. 21:66-71
Clinical data on the efficacy and safety of cetuximab and panitumumab in 87 patients in the 1-4 lines of drug therapy for metastatic colorectal cancer (mCRC) with wild-type RAS with and without surgical removal of metastases were analyzed. Anti-EGFR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e5236977cf965dfd93f8eaa2da59581
https://doi.org/10.18821/1028-9984-2016-21-1-66-71
Zobrazit plný text záznamu
6
Effect of cetuximab on development of viral infectious complications in laryngeal cancer
Autor: Irina L. Popova, Aza A. Agieva, Natalya Mikhailovna Tikhanovskaya, Ludmila A. Ryadinskaya, Yulia V. Ulianova, Tatiana A. Zykova, Marina A. Engibaryan, A. E. Storozhakova, Irina Viktorovna Pustovaya, Natalya A Abramova, Liubov Yu Vladimirova
Publikováno v: Journal of Clinical Oncology. 35:e17578-e17578
e17578 Background: Cytostatic treatment was shown to influence significantly reactivation of latent viral infections. Our purpose was to study the possible effect of cetuximab on activation of herpesvirus infections. Methods: The blood serum of patie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ec9d286f8ebcd7972c83ac1582c4847
https://doi.org/10.1200/jco.2017.35.15_suppl.e17578
Zobrazit plný text záznamu
7
Dynamics of growth of transplantable sarcoma 45 (S45) in injection of autologous and allogenic serum
Autor: Aza A. Agieva, Irina L. Popova, Elena Yurievna Zlatnik, Mariya Yezhova, Natalya A Abramova, Liubov Yu Vladimirova
Publikováno v: Journal of Clinical Oncology. 34:e23009-e23009
e23009Background: Development and administration of antibody drugs for tumor immunotherapy are now one of the growing tendencies in oncology and immunology. The purpose of the study was to study th...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34ceed89c97cc0f4eedda7859083b400
https://doi.org/10.1200/jco.2016.34.15_suppl.e23009
Zobrazit plný text záznamu
8
Role of endothelial-specific growth-factors in efficacy of cetuximab in pts with head and neck squamous cell carcinoma (HNSCC)
Autor: Liubov Yu Vladimirova, Yulia A. Pogorelova, Aza A. Agieva, Marina A. Engibaryan, Natalya A Abramova, Irina Viktorovna Pustovaya, Elena M. Frantsiyants
Publikováno v: Journal of Clinical Oncology. 33:e17013-e17013
e17013 Background: The EGFR transduction pathway is known to regulate tumor angiogenesis. Impairments in this growth factor system could be a reason for inappropriate tumor response. The aim of the...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67575ef6c4296592209b64dd3ac2c9c6
https://doi.org/10.1200/jco.2015.33.15_suppl.e17013
Zobrazit plný text záznamu
9
Growth-factors system in anti-EGFR monoclonal antibody therapy in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)
Autor: Aza A. Agieva, Elena M. Frantsiyants, Liubov Yu Vladimirova, Marina A. Engibaryan, Irina L. Popova, Natalia D. Cheryarina
Publikováno v: Journal of Clinical Oncology. 33:e17014-e17014
e17014 Background: AntiEGFR monoclonal-antibody cetuximab (C) is proved to increase the efficacy of the treatment of patiens with HNSCC. Meanwhile not all the patients have the tumor response. The ...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc4bbb58f76e8b4fc9302e418c757695
https://doi.org/10.1200/jco.2015.33.15_suppl.e17014
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje